Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: Potential breast cancer risk alleles and their distribution across human populations

Human Genomics

Volumn 2, Issue 5, 2006, Pages 287-296

  Savas, Sevtap ^a,b   Schmidt, Steffen ^c   Jarjanazi, Hamdi ^a,b   Ozcelik, Hilmi ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Breast cancer predisposition; Breast tissue expression; Carcinogenesis related genes; nsSNPs; PolyPhen

Indexed keywords

ONCOPROTEIN;

ALLELE; ARTICLE; BIOINFORMATICS; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CANCER THERAPY; CARCINOGENESIS; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENE FREQUENCY; GENE IDENTIFICATION; HEREDITY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; POPULATION DISTRIBUTION; POPULATION GENETICS; PREDICTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE DISTRIBUTION; UNINDEXED SEQUENCE; VALIDATION PROCESS;

EID: 33645242182     PISSN: 14797364     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-2-5-287     Document Type: Article

References (67)

1. Miki, Y, Swensen, J., Shattuck-Eidens, D. et al. (1994), 'A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1', Science Vol. 266, pp. 66-71.
2. Wooster, R., Bignell, G., Lancaster, J. et al. (1995), 'Identification of the breast cancer susceptibility gene BRCA2', Nature Vol. 378, pp. 789-792.
3. Hofmann, W. and Schlag, P.M. (2000), 'BRCA1 and BRCA2 - Breast cancer susceptibility genes', J. Cancer Res. Clin. Oncol. Vol. 126, pp. 487-496.
4. Hodgson, S.V, Morrison, P.J. and Irving, M. (2004), 'Breast cancer genetics: Unsolved questions and open perspectives in an expanding clinical practice', Am. J. Med. Genet. C Semin. Med. Genet. Vol. 129, pp. 56-64.
5. Dong, C. and Hemminki, K. (2001), 'Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families', Int. J. Cancer Vol. 92, pp. 144-150.
6. Chenevix-Trench, G., Spurdle, A.B., Gatei, M. et al. (2002), 'Dominant negative ATM mutations in breast cancer families', J. Natl. Cancer Inst. Vol. 94, pp. 205-215.
7. Ponder, B.A. (2001), 'Cancer genetics', Nature Vol. 411, pp. 336-341.
8. Malkin, D., Li, F.P., Strong, L.C. et al. (1990), 'Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms', Science Vol. 250, pp. 1233-1238.
9. Meijers-Heijboer, H., van den Ouweland, A., Klijn, J. et al. (2002), 'Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations', Nat. Genet. Vol. 31, pp. 55-59.
10. Risch, N. and Merikangas, K. (1996), 'The future of genetic studies of complex human diseases', Science Vol. 273, pp. 1516-1517.
11. Collins, A., Lonjou, C. and Morton, N.E. (1999), 'Genetic epidemiology of single-nucleotide polymorphisms', Proc. Natl. Acad. Sci. USA Vol. 96, pp. 15173-15177.
12. Houlston, R.S. and Peto, J. (2004), 'The search for low-penetrance cancer susceptibility alleles', Oncogene Vol. 23, pp. 6471-6476.
13. Reumers, J., Schymkowitz, J., Ferkinghoff-Borg, J. et al. (2005), 'SNPeffect: A database mapping molecular phenotypic effects of human non-synonymous coding SNPs', Nucleic Acids Res. Vol. 33(Database Issue), pp. D527-D532.
14. Chanock, S. (2001), 'Candidate genes and single nucleotide polymorphisms (SNPs) in the study of human disease', Dis. Markers Vol. 17, pp. 89-98.
15. Pharoah, P.D., Dunning, A.M., Ponder, B.A. and Easton, D.E. (2004), 'Association studies for finding cancer-susceptibility genetic variants', Nat. Rev. Cancer Vol. 4, pp. 850-860.
16. Wang, Z. and Moult, J. (2001), 'SNPs, protein structure, and disease', Hum. Mutat. Vol. 17, pp. 263-270.
17. Ng, P.C. and Henikoff, S. (2002), 'Accounting for human polymorphisms predicted to affect protein function', Genome Res. Vol. 12, pp. 436-446.
18. Ramensky; V, Bork, P. and Sunyaev, S. (2002), 'Human non-synonymous SNPs: Server and survey', Nucleic Acids Res. Vol. 30, pp. 3894-3900.
19. MacPherson, G., Healey, C.S., Teare, M.D. et al. (2004), 'Association of a common variant of the CASP8 gene with reduced risk of breast cancer', J. Natl. Cancer Inst. Vol. 96, pp. 1866-1869.
20. Menzel, H.J., Sarmanova, J., Soucck, P. et al. (2004), 'Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations', Br. J. Cancer Vol. 90, pp. 1989-1994.
21. Rutter, J.L., Chatterjee, N., Wacholder, S. and Struewing, J. (2003), 'The HER2 I655V polymorphism and breast cancer risk in Ashkenazim', Epidemiology Vol. 14, pp. 694-700.
22. Livingston, R.J., von Niederhausern, A., Jegga, A.G. et al. (2004), 'Pattern of sequence variation across 213 environmental response genes', Genome Res. Vol. 14, pp. 1821-1831.
23. Savas, S., Kim, D.Y, Ahmad, M.F. et al. (2004), 'Identifying functional genetic variants in DNA repair pathway using protein conservation analysis', Cancer Epidemiol. Biomarkers Prev. Vol. 13, pp. 801-807.
24. Xi, T, Jones, I.M. and Mohrenweiser, H.W (2004), 'Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function', Genomics Vol. 83, pp. 970-979.
25. Savas, S., Ahmad, M.F., Shariff, M. et al. (2005), 'Candidate nsSNPs that can affect the functions and interactions of cell cycle proteins', Proteins Vol. 58, pp. 697-705.
26. Ben-Shlomo, I., Vitt, U.A. and Hsueh, AJ. (2002), 'Perspective: The ovarian kaleidoscope database-II. Functional genomic analysis of an organ-specific database', Endocrinology Vol. 143, pp. 2041-2044.
27. Morton, C.C. (2004), 'Gene discovery in the auditory system using a tissue specific approach', Am. J. Med. Genet. A Vol. 130, pp. 26-28.
28. Hubbard, T, Andrews, D., Caccamo, M. et al. (2005), 'Ensembl 2005', Nucleic Acids Res. Vol. 33(Database Issue), pp. D447-D453.
29. Skrabanek, L. and Campagne, E (2001), 'TissueInfo: High-throughput identification of tissue expression profiles and specificity', Nucleic Acids Res. Vol. 29, pp. E102-2.
30. Clifford, R., Edmonson, M., Hu, Y et al. (2000), 'Expression-based genetic/physical maps of single-nucleotide polymorphisms identified by the cancer genome anatomy project', Genome Res. Vol. 10, pp. 1259-1265.
31. Sherry, S.T., Ward, M.H., Kholodov, M. et al. (2001),'dbSNP: The NCBI database of genetic variation', Nucleic Acids Res. Vol. 29, pp. 308-311.
32. Daly, A.K. and Day, C.P. (2001), 'Candidate gene case-control association studies: Advantages and potential pitfalls', Br. J. Clin. Pharmacol. Vol. 52, pp. 489-499.
33. Sunyaev, S., Ramensky, V, Koch, I. et al. (2001), 'Prediction of deleterious human alleles', Hum. Mol. Genet. Vol. 10, pp. 591-597.
34. Jakobisiak, M., Lasek, W. and Golab, J. (2003), 'Natural mechanisms protecting against cancer', Immunol. Lett. Vol. 90, pp. 103-122.
35. Kirsch, M., Schackert, G. and Black, P.M. (2004), 'Metastasis and angiogenesis', Cancer Treat. Res. Vol. 117, pp. 285-304.
36. Mohrenweiser, H.W. (2004), 'Genetic variation and exposure related risk estimation: Will toxicology enter a new era? DNA repair and cancer as a paradigm', Toxicol. Pathol. Vol. 32, pp. 136-145.
37. Andreassen, C.N., Alsner, J., Overgaard, M. and Overgaard, J. (2003), 'Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes', Radiother. Oncol. Vol. 69, pp. 127-135.
38. Watters, J.W and McLeod, H.L. (2003), 'Cancer pharmacogenomics: Current and future applications', Biochim. Biophys. Acta Vol. 1603, pp. 99-111.
39. Sullivan, A., Syed, N., Gasco, M. et al. (2004), 'Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo', Oncogene Vol. 23, pp. 3328-3337.
40. Oehler, M.K., Fischer, D.C., Orlowska-Volk, M. et al. (2003), 'Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer', Br. J. Cancer Vol. 89, pp. 1927-1933.
41. Cakir, Y, Plummer, H.K. 3rd, Tithof, RK. and Schuller, H.M. (2002), 'Beta-adrenergic and arachidonic acid-mediated growth regulation of human breast cancer cell lines', Int. J. Oncol. Vol. 21, pp. 153-157.
42. Zunarefli, E., Nicoll, J.A., Migaldi, M. and Trentini, G.P. (2000), 'Apolipoprotein E polymorphism and breast carcinoma: Correlation with cell proliferation indices and clinical outcome', Breast Cancer Res. Treat. Vol. 63, pp. 193-198.
43. Pagani, A., Papotti, M., Hofler, H. et al. (1990), 'Chromogranin A and B gene expression in carcinomas of the breast. Correlation of immunocytochemical, immunoblot, and hybridization analyses', Am. J. Pathol. Vol. 136, pp. 319-327.
44. Lin, E.Y., Gouon-Evans, V., Nguyen, A.V. and Pollard, J.W. (2002), 'The macrophage growth factor CSF-1 in mammary gland development and tumor progression', J. Mammary Gland Biol. Neoplasia Vol. 7, pp. 147-162.
45. Spink, D.C., Spink, B.C., Cao, J.Q. et al. (1998), 'Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells', Carcinogenesis Vol. 19, pp. 291-298.
46. Sgambato, A., Migaldi, M., Montanari, M. et al. (2003), 'Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression', Am. J. Pathol. Vol. 162, pp. 849-860.
47. Li, C., Guo, B., Bernabeu, C. and Kumar, S. (2001), 'Angiogenesis in breast cancer: The role of transforming growth factor beta and CD105', Microsc. Res. Tech. Vol. 52, pp. 437-449.
48. Fritz, P., Murdter, T.E., Eichelbaum, M. et al. (2001), 'Microsomal epoxide hydrolase expression as a predictor of tamoxifen response in primary breast cancer: A retrospective exploratory study with long-term follow-up', J. Clin. Oncol. Vol. 19, pp. 3-9.
49. Zhou, B.P. and Hung, M.C. (2003), 'Dysregulation of cellular signaling by HER2/neu in breast cancer', Semin. Oncol. Vol. 30, pp. 38-48.
50. Booden, M.A., Eckert, L.B., Der, C.J. and Trejo, J. (2004), 'Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion', Mol. Cell. Biol. Vol. 24, pp. 1990-1999.
51. Lee, P.P., Hwang, J.J., Murphy, G. and Ip, M.M. (2000), 'Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells', Endocrinology Vol. 141, pp. 3764-3773.
52. Carraway, K.L., Price-Schiavi, S.A., Komatsu, M. et al. (2001), 'Muc4/ sialomucin complex in the mammary gland and breast cancer', J. Mammary Gland Biol. Neoplasia Vol. 6, pp. 323-337.
53. Jauliac, S., Lopez-Rodriguez, C., Shaw, L.M. et al. (2002), 'The role of NFAT transcription factors in integrin-mediated carcinoma invasion', Nat. Cell. Biol. Vol. 4, pp. 540-544.
54. Politi, K., Feirt, N. and Kitajewski, J. (2004), 'Notch in mammary gland development and breast cancer', Semin. Cancer Biol. Vol. 14, pp. 341-347.
55. Sliva, D. (2004), 'Signaling pathways responsible for cancer cell invasion as targets for cancer therapy', Curr. Cancer Drug Targets Vol. 4, pp. 327-336.
56. Singh, B. and Lucci, A. (2002), 'Role of cyclooxygenase-2 in breast cancer', J. Surg. Res. Vol. 108, pp. 173-179.
57. O'Hanlon, D.M., Fitzsimons, H., Lynch, J. et al. (2002), 'Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma', Eur. J. Cancer Vol. 38, pp. 2252-2257.
58. Cavalli-Sforza, L.L. and Feldman, M.W. (2003), 'The application of molecular genetic approaches to the study of human evolution', Nat. Genet. Vol. 33, pp. 266-275.
59. Fay, J.C. and Wu, C.I. (2003), 'Sequence divergence, functional constraint, and selection in protein evolution', Annu. Rev. Genomics Hum, Genet. Vol. 4, pp. 213-235.
60. London, S.J., Lehman, T.A. and Taylor, J.A. (1997), 'Myeloperoxidase genetic polymorphism and lung cancer risk', Cancer Res. Vol. 57, pp. 5001-5003.
61. Evans, D.A., McLeod, H.L., Pritchard, S. et al. (2001), 'Interethnic variability in human drug responses', Drug Metab. Dispos. Vol. 29, pp. 606-610.
62. Gibson, A.W., Edberg, J.C., Wu, J. et al. (2001), 'Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus', J. Immunol. Vol. 166, pp. 3915-3922.
63. Hopper, J.L. (2001), 'Genetic epidemiology of female breast cancer', Semin. Cancer Biol. Vol. 11, pp. 367-374.
64. Xu, C., Goodz, S., Sellers, E.M. and Tyndale, R.F. (2002), 'CYP2A6 genetic variation and potential consequences', Adv. Drug Deliv. Rev. Vol. 54, pp. 1245-1256.
65. Shimizu, E., Hashimoto, K. and Iyo, M. (2004), 'Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: The possibility to explain ethnic mental traits', Am. J. Med. Genet. B Neuropsychiatr. Genet. Vol. 126, pp. 122-123.
66. Wang, S.M. and Rowley, J.D. (1998), 'A strategy for genome-wide gene analysis: Integrated procedure for gene identification', Proc. Natl. Acad. Sci. USA Vol. 95, pp. 11909-11914.
67. Povey, S., Lovering, R., Bruford, E. et al. (2001), 'The HUGO Gene Nomenclature Committee (HGNC)', Hum. Genet. Vol. 109, pp. 678-680.